---
title: "Goldman Sachs Sticks to Its Buy Rating for CStone Pharmaceuticals (2616)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281161090.md"
description: "Goldman Sachs analyst maintained a Buy rating on CStone Pharmaceuticals yesterday and set a price target of HK$9.44. The company’s shares closed today at HK$8.75.End of Quarter Sale - 50% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on CStone Pharmaceuticals is a Moderate Buy with an average price target of HK$9.87."
datetime: "2026-03-31T09:26:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281161090.md)
  - [en](https://longbridge.com/en/news/281161090.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281161090.md)
---

# Goldman Sachs Sticks to Its Buy Rating for CStone Pharmaceuticals (2616)

Goldman Sachs analyst maintained a Buy rating on CStone Pharmaceuticals yesterday and set a price target of HK$9.44. The company’s shares closed today at HK$8.75.

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Currently, the analyst consensus on CStone Pharmaceuticals is a Moderate Buy with an average price target of HK$9.87.

### Related Stocks

- [02616.HK](https://longbridge.com/en/quote/02616.HK.md)

## Related News & Research

- [CStone Pharmaceuticals Unveils Share Buyback Plan After Key Oncology Data Milestone](https://longbridge.com/en/news/286244356.md)
- [CStone Pharmaceuticals Raises Over HK$1 Billion in Completed Share Placement](https://longbridge.com/en/news/283702622.md)
- [Goldman Sachs Reaffirms Their Buy Rating on Prudential (PRU)](https://longbridge.com/en/news/286866728.md)
- [Positive Report for Sinotruk Hong Kong (3808) from Bank of America Securities](https://longbridge.com/en/news/286848185.md)
- [This Analyst Just Sent Mobileye Stock Down. Here's Why.](https://longbridge.com/en/news/286817003.md)